Boehringer Ingelheim Vetmedica Mergers and Acquisitions Summary

Life Science Company

Boehringer Ingelheim Vetmedica has acquired 0 companies. It has also divested 2 assets.

It’s largest disclosed sale occurred in 2016, when it sold Boehringer Ingelheim Vetmedica - U.S. Feline Canine and Rabies Vaccines to Elanco Animal Health for $885M.

Join Mergr and gain access to Boehringer Ingelheim Vetmedica’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Sell Activity2
  • M&A Buy/Sell Connections 2

Boehringer Ingelheim Vetmedica, Inc.

3902 Gene Field Road,
St. Joseph, Montana 64506
United States,
(866) 638-2226

Boehringer Ingelheim Vetmedica, Inc. is a developer of innovative vaccines and pharmaceuticals with the highest therapeutic value in the cattle, equine, pet and swine markets.

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.4/yr) # - 1 1 - - - 2
vol $885M $885M

Most Recent M&A

Company Date Value Type
Boehringer Ingelheim Vetmedica, Inc. - Cydectin 2017-01-04 - Divestiture
St. Joseph, Montana
Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines 2016-10-05 885M USD Divestiture
St. Joseph, Montana
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 2 (100%) 885M (100%)
Total - - 2 $885M

By Geo

State/Country Buy Value Sell Value
United States - - 2 885M
  Montana - - 2 885M
Total - - 2 $885M

Deal Values

sell # Total
$100M to $1B 1 $885M
Largest Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines
$885M (2016-10-05)

M&A Connections

Deals %
Divested to
2 100%

 Subscribe to unlock this and 154,308
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.0K Private Equity Firms
  • 142K M&A Transactions
  • 150K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 43K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.